Latest Breaking News On - Director corporate communication - Page 2 : comparemela.com

BioArctic: Leqembi® revenue totaled JPY 2 83 billion in the first quarter 2024

BioArctic: Leqembi® revenue totaled JPY 2 83 billion in the first quarter 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Oskar bossonJiang millingtonDennis riedlLecanemab leqembiAlzheimer clinical trial consortiumAlzheimer network trials unitNational institutes of healthVp communicationsWashington university school of medicineEuropean unionNational institute onNasdaq stockholmDirector corporate communicationSocial mediaNew england journalClinical trial consortium

Leqembi® revenue totaled JPY 2 83 billion in the first quarter 2024

/PRNewswire/ BioArctic AB s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the first.

Lecanemab leqembiJiang millingtonOskar bossonNational institute onEuropean unionWashington university school of medicineVp communicationsNational institutes of healthAlzheimer network trials unitAlzheimer clinical trial consortiumNasdaq stockholmDirector corporate communicationSocial mediaNew england journalClinical trial consortiumNational institute

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress

BioArctic: New data on lecanemab presented at the 2024 AD/PD™ congress
prnewswire.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.co.uk Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainJiang millingtonOskar bossonLars lannfeltGunilla osswaldWashington university school of medicineVp communicationsInternational conference on alzheimerNational institute onNational institutes of healthDrug administrationAlzheimer network trials unitMinistry of healthAlzheimer clinical trial consortiumNational medical products administration

BioArctic: New data on lecanemab presented at the 2024 AD/PDtm congress

BioArctic: New data on lecanemab presented at the 2024 AD/PDtm congress
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainOskar bossonJiang millingtonLars lannfeltGunilla osswaldAlzheimer network trials unitNational institutes of healthNational institute onMinistry of healthNational medical products administrationWashington university school of medicineDrug administrationAlzheimer clinical trial consortiumInternational conference on alzheimerVp communications

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress

BioArctic: Latest data on lecanemab to be presented at the 2024 AD/PD™ congress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomGreat britainMiia kivipeltoLars lannfeltLynn kramerJeffrey cummingsJiang millingtonOskar bossonRobert perneczkyMinistry of healthNational institute onDrug administrationWashington university school of medicineInternational conference on alzheimerVp communicationsNational institutes of health